July 21, 2026
The D.C. Circuit on Tuesday upheld a lower court's finding that U.S. Department of Health and Human Services has the authority to block or approve drugmakers' efforts to implement rebates instead of discounts under the 340B drug-pricing program.
May 19, 2025
A D.C. federal judge awarded an early win to the U.S. Department of Health and Human Services on Friday on claims it illegally blocked drugmakers' efforts to implement rebates instead of discounts in a decades-old drug pricing program, finding the agency has the authority to pre-approve the price reduction models.
October 07, 2021
The U.S. Department of Health and Human Services is wrongly barring drugmakers from requiring claims information from certain health providers when they request a ceiling price for drugs under a federal discount program, according to a new lawsuit.